Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours-Reference-Cited by-同舟云学术

Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours

Published:2010-01 Issue:1 Volume:46 Page:198-206
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Gregorc Vanesa,Citterio Giovanni,Vitali Giordano,Spreafico Anna,Scifo Paola,Borri Anna,Donadoni Giovanni,Rossoni Gilda,Corti Angelo,Caligaris-Cappio Federico,Maschio Alessandro Del,Esposito Antonio,De Cobelli Francesco,Dell’Acqua Flavio,Troysi Antonella,Bruzzi Paolo,Lambiase Antonio,Bordignon Claudio

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. An endotoxin-induced serum factor that causes necrosis of tumours;Carswell;Proc Natl Acad Sci USA,1975

2. Efficiency of recombinant human TNF in human cancer therapy;Lejeune;Cancer Immun,2006

3. A phase I clinical trial of recombinant human tumour necrosis factor given daily for five days;Creaven;Cancer Chemother Pharmacol,1989

4. Phase I trial of recombinant human tumour necrosis factor alpha in patients with advanced malignancy;Gamm;Eur J Cancer,1991

5. Phase I study of recombinant human tumour necrosis factor;Kimura;Cancer Chemother Pharmacol,1987

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the Blood–Brain Tumor Barrier with Tumor Necrosis Factor-α;Pharmaceutics;2022-07-06

2. Current understandings and clinical translation of nanomedicines for breast cancer therapy;Advanced Drug Delivery Reviews;2022-01

3. Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein;Neuro-Oncology;2021-07-23

4. Optimal biological dose: a systematic review in cancer phase I clinical trials;BMC Cancer;2021-01-13

5. Small molecule drug conjugates (SMDCs): an emerging strategy for anticancer drug design and discovery;New Journal of Chemistry;2021